GLOBUS MEDICAL INC - Class A Stock (GMED)

CUSIP: 379577208

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class
Equity / Class A Stock
Shares outstanding
115,244,363
Total 13F shares
68,045,932
Share change
+303,730
Total reported value
$5,276,020,366
Put/Call ratio
9%
Price per share
$77.53
Number of holders
351
Value change
+$27,082,820
Number of buys
164
Number of sells
145

Quarterly Holders Quick Answers

What is CUSIP 379577208?
CUSIP 379577208 identifies GMED - GLOBUS MEDICAL INC - Class A Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of GMED - GLOBUS MEDICAL INC - Class A Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BlackRock Finance, Inc.
13F
Company
6.6%
7,561,883
$466,342,000 31 Mar 2021
13F
VANGUARD GROUP INC
13F
Company
6.2%
7,097,808
$437,722,000 31 Mar 2021
13F
JANUS HENDERSON GROUP PLC
13F
Company
5.6%
6,422,806
$396,094,000 31 Mar 2021
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
3.1%
3,614,076
$222,879,000 31 Mar 2021
13F
Capital Research Global Investors
13F
Company
1.8%
2,053,234
$126,623,000 31 Mar 2021
13F
STATE STREET CORP
13F
Company
1.7%
1,938,130
$119,524,000 31 Mar 2021
13F
RTW INVESTMENTS, LP
13F
Company
1.4%
1,670,811
$103,039,000 31 Mar 2021
13F
AXA S.A.
13F
Company
1.3%
1,541,062
$95,038,000 31 Mar 2021
13F
Champlain Investment Partners, LLC
13F
Company
1.3%
1,520,725
$93,783,000 31 Mar 2021
13F
GW&K Investment Management, LLC
13F
Company
1.3%
1,489,462
$91,855,000 31 Mar 2021
13F
Van Berkom & Associates Inc.
13F
Company
1.3%
1,474,699
$90,945,000 31 Mar 2021
13F
GENEVA CAPITAL MANAGEMENT LLC
13F
Company
1.1%
1,277,448
$78,781,000 31 Mar 2021
13F
AMERIPRISE FINANCIAL INC
13F
Company
1%
1,193,460
$73,599,000 31 Mar 2021
13F
Invesco Ltd.
13F
Company
1%
1,162,469
$71,689,000 31 Mar 2021
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.91%
1,049,697
$64,734,000 31 Mar 2021
13F
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC
13F
Company
0.88%
1,018,888
$62,835,000 31 Mar 2021
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
0.75%
863,318
$53,241,000 31 Mar 2021
13F
Bank of New York Mellon Corp
13F
Company
0.7%
807,310
$49,788,000 31 Mar 2021
13F
FMR LLC
13F
Company
0.7%
804,579
$49,619,000 31 Mar 2021
13F
NORDEA INVESTMENT MANAGEMENT AB
13F
Company
0.65%
749,302
$46,045,000 31 Mar 2021
13F
Polar Capital Holdings Plc
13F
Company
0.61%
700,152
$43,178,000 31 Mar 2021
13F
MARATHON ASSET MANAGEMENT LLP
13F
Company
0.58%
666,357
$41,094,000 31 Mar 2021
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.57%
660,104
$40,707,000 31 Mar 2021
13F
Bellevue Group AG
13F
Company
0.56%
647,509
$39,932,000 31 Mar 2021
13F
NORTHERN TRUST CORP
13F
Company
0.56%
643,183
$39,665,000 31 Mar 2021
13F
Pembroke Management, LTD
13F
Company
0.53%
614,826
$37,916,000 31 Mar 2021
13F
NORGES BANK
13F
Company
0.53%
614,299
$37,884,000 31 Mar 2021
13F
PARADIGM CAPITAL MANAGEMENT INC/NY
13F
Company
0.52%
600,300
$37,021,000 31 Mar 2021
13F
Consonance Capital Management LP
13F
Company
0.5%
578,371
$35,668,000 31 Mar 2021
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.48%
554,201
$34,177,000 31 Mar 2021
13F
Boston Trust Walden Corp
13F
Company
0.43%
500,223
$30,849,000 31 Mar 2021
13F
NUANCE INVESTMENTS, LLC
13F
Company
0.42%
486,325
$29,992,000 31 Mar 2021
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.41%
475,447
$29,321,000 31 Mar 2021
13F
LOOMIS SAYLES & CO L P
13F
Company
0.41%
470,853
$29,038,000 31 Mar 2021
13F
ROYAL BANK OF CANADA
13F
Company
0.39%
454,426
$28,025,000 31 Mar 2021
13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE
13F
Company
0.36%
417,014
$25,717,000 31 Mar 2021
13F
Legal & General Group Plc
13F
Company
0.34%
392,938
$24,233,000 31 Mar 2021
13F
EAGLE ASSET MANAGEMENT INC
13F
Company
0.29%
331,223
$20,486,000 31 Mar 2021
13F
BALYASNY ASSET MANAGEMENT L.P.
13F
Company
0.28%
328,401
$20,252,000 31 Mar 2021
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.27%
309,065
$19,060,000 31 Mar 2021
13F
Global Alpha Capital Management Ltd.
13F
Company
0.25%
292,637
$18,047,000 31 Mar 2021
13F
VOYA INVESTMENT MANAGEMENT LLC
13F
Company
0.25%
283,333
$17,473,000 31 Mar 2021
13F
Aberdeen Group plc
13F
Company
0.24%
280,580
$17,305,000 31 Mar 2021
13F
Nuveen Asset Management, LLC
13F
Company
0.24%
276,646
$17,061,000 31 Mar 2021
13F
PRINCIPAL FINANCIAL GROUP INC
13F
Company
0.23%
265,507
$16,374,000 31 Mar 2021
13F
Vident Investment Advisory, LLC
13F
Company
0.22%
256,194
$15,799,000 31 Mar 2021
13F
Swedbank AB
13F
Company
0.22%
255,000
$15,725,850 31 Mar 2021
13F
Retirement Systems of Alabama
13F
Company
0.22%
253,173
$15,613,000 31 Mar 2021
13F
SEGALL BRYANT & HAMILL, LLC
13F
Company
0.21%
244,765
$15,099,000 31 Mar 2021
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.2%
232,125
$14,315,000 31 Mar 2021
13F

Institutional Holders of GLOBUS MEDICAL INC - Class A Stock (GMED) as of Q2 2021

As of 30 Jun 2021, GLOBUS MEDICAL INC - Class A Stock (GMED) was held by 351 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 68,045,932 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, JANUS HENDERSON GROUP PLC, WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, Capital Research Global Investors, RTW INVESTMENTS, LP, Champlain Investment Partners, LLC, GW&K Investment Management, LLC, and AXA S.A.. This page lists 351 institutional shareholders reporting positions in this security for the Q2 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2021 vs Q1 2021 Across Filers

Q1 2021 holders
338
Q2 2021 holders
351
Holder diff
13
Investor Q1 2021 Shares Q2 2021 Shares Share Diff Share Chg % Q1 2021 Value $ Q2 2021 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.